Creo Medical Group "knows what it needs to do" after "terrific" 2022
News release
by
Creo Medical Group PLC
London, UK
|
May 04, 2023 08:05 AM Eastern Daylight Time
Creo Medical Group PLC (AIM:CREO) CEO Craig Gulliford speaks to Thomas Warner from Proactive after releasing full year results for calendar year 2022 - a year he describes as "terrific" for the endoscopy-focused medical device company.
Gulliford also gives the highlights from the post-period, which included an oversubscribed £33.7mln gross fundraise in March of 2023, and says Creo "knows what [it] needs to do" moving forward.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
